Search Results - "BRENSIKE, J. F"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2
  3. 3

    Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease by Borer, J S, Brensike, J F, Redwood, D R, Itscoitz, S B, Passamani, E R, Stone, N J, Richardson, J M, Levy, R I, Epstein, S E

    Published in The New England journal of medicine (21-08-1975)
    “…The electrocardiographic response to exercise was compared with the results of coronary angiography in 89 patients with Type II hyperlipoproteinemia who had…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Secondary prevention and lipid lowering: results and implications by Detre, K M, Levy, R I, Kelsey, S F, Epstein, S E, Brensike, J F, Passamani, E R, Richardson, J M, Loh, I K, Stone, N J, Aldrich, R F

    Published in The American heart journal (01-11-1985)
    “…In a secondary prevention trial conducted by the National Heart, Lung, and Blood Institute, the effect of lipid lowering by drug intervention on the…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Reliability of assessing change with sequential coronary angiography by Detre, K M, Kelsey, S F, Passamani, E R, Fisher, M R, Brensike, J F, Battaglini, J W, Richardson, J M, Loh, I K, Stone, N J, Aldrich, R F, Levy, R I, Epstein, S E

    Published in The American heart journal (01-10-1982)
    “…Data are presented from a study evaluating the reliability of sequential angiography in estimating changes in coronary lesions. Three panels of three expert…”
    Get more information
    Journal Article
  9. 9

    National Heart, Lung, and Blood Institute type II Coronary Intervention Study: design, methods, and baseline characteristics by Brensike, J F, Kelsey, S F, Passamani, E R, Fisher, M R, Richardson, J M, Loh, I K, Stone, N J, Aldrich, R F, Battaglini, J W, Moriarty, D J, Myrianthopoulos, M B, Detre, K M, Epstein, S E, Levy, R I

    Published in Controlled clinical trials (01-06-1982)
    “…The Type II Coronary Intervention Study (Type II Study) is a double-blind, randomized, placebo-controlled clinical trial conducted by the Division of…”
    Get more information
    Journal Article